The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com

Autolus Therapeutics PLC Stock Forecast

Recent Autolus Therapeutics PLC Stock Price   Autolus Therapeutics PLC Stock Forecast Price
$4.08 Autolus Therapeutics PLC stock forecast: higher
+130.39%
$9.40
 As of 2024-04-26
Recent Autolus Therapeutics PLC Analyst Ratings Breakdown
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 6 6 6 6
Buy ratings: 1 1 1 1
Hold ratings: 1 1 1 1
Sell ratings: 0 0 0 0
Strong sell ratings: 0 0 0 0
Average rating: 1.38 1.38 1.38 1.38
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

The presented Autolus Therapeutics PLC stock forecast (traded under symbol AUTL), for forward-twelve-months price target as shown at the top of this page, gives you the average Autolus Therapeutics PLC stock forecast for forward target price for symbol AUTL, across the 7 analysts covering Autolus Therapeutics PLC (AUTL), as reported in data provided by Zacks Investment Research via Quandl.com.

Investors should also take note that the median Autolus Therapeutics PLC stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Autolus Therapeutics PLC stock forecast and half had a lower Autolus Therapeutics PLC stock forecast) was $10.0 as of 2024-04-26 (which is a different mathematical metric versus taking the average or mean), while the highest Autolus Therapeutics PLC stock forecast in the analyst group was $12.0, and the lowest Autolus Therapeutics PLC stock forecast in the analyst group was $4.8, with a standard deviation of $2.433. Get the latest Zacks research report on AUTL — FREE

Slideshow Top Analyst Picks of the Dow
Slideshow The Top 20 Largest U.S. Stocks By Market Cap

Company Name:  Autolus Therapeutics PLC
Website:  www.autolus.com
Sector:  Biotechnology
Number of ETFs Holding AUTL:  4
Total Market Value Held by ETFs:  $271800
April 28, 2024    3:23 PM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree AUTL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.62 out of 4)
64th percentile
(ranked higher than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Autolus Therapeutics PLC Stock Forecast (AUTL) | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.